Nucleus Replacement - Medical Devices Pipeline Assessment, 2017

2017-06-14
Price :
Published : Jun-2017
No. of Pages : 63
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Nucleus Replacement Overview 6
3 Products under Development 7
3.1 Nucleus Replacement - Pipeline Products by Stage of Development 7
3.2 Nucleus Replacement - Pipeline Products by Territory 8
3.3 Nucleus Replacement - Pipeline Products by Regulatory Path 9
3.4 Nucleus Replacement - Pipeline Products by Estimated Approval Date 10
3.5 Nucleus Replacement - Ongoing Clinical Trials 11
4 Nucleus Replacement - Pipeline Products under Development by Companies 12
4.1 Nucleus Replacement Companies - Pipeline Products by Stage of Development 12
4.2 Nucleus Replacement - Pipeline Products by Stage of Development 13
5 Nucleus Replacement Companies and Product Overview 14
5.1 Arthro Kinetics AG Company Overview 14
5.1.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Chi2Gel Ltd. Company Overview 15
5.2.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Clariance Inc Company Overview 16
5.3.1 Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 CryoLife Inc Company Overview 17
5.4.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 DePuy Synthes Inc Company Overview 18
5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Gentis Inc Company Overview 19
5.6.1 Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Hydrospine, Inc. Company Overview 20
5.7.1 Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 Ortho Regenerative Technologies Inc Company Overview 21
5.8.1 Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 Raymedica, LLC Company Overview 22
5.9.1 Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.10 Replication Medical Inc Company Overview 23
5.10.1 Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
5.11 Spine Wave Inc Company Overview 24
5.11.1 Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.12 Stryker Corporation Company Overview 26
5.12.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
5.13 TranS1 Inc Company Overview 27
5.13.1 TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.14 Vertebral Technologies Inc Company Overview 28
5.14.1 Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.15 Zimmer Biomet Holdings Inc Company Overview 31
5.15.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 31
6 Nucleus Replacement- Recent Developments 33
6.1 Apr 27, 2017: SpinalCyte Receives New Australian Patent 33
6.2 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results 33
6.3 Apr 27, 2017: RTI Surgical Announces 2017 First Quarter Results 34
6.4 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 35
6.5 Apr 25, 2017: Stryker reports first quarter 2017 results 36
6.6 Apr 12, 2017: Brian May Joins Spine Wave as Executive Vice President, Research and Development 37
6.7 Apr 06, 2017: SpinalCyte Receives New European Patent 37
6.8 Feb 23, 2017: RTI Surgical Announces 2016 Fourth Quarter, Full Year Results; Initiates Actions to Improve Execution and Return to Profitable Growth 38
6.9 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 40
6.10 Feb 09, 2017: SpinalCyte Announces New U.S. Patent 41
6.11 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 41
6.12 Jan 26, 2017: RTI Surgical Names Camille Farhat Chief Executive Officer 42
6.13 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 43
6.14 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 45
6.15 Jan 17, 2017: RTI Surgical Extends Deadline for Nominating Directors to the Board 45
6.16 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 45
6.17 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 46
6.18 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 47
6.19 Dec 14, 2016: RTI Surgical Names Robert P. Jordheim Interim CEO 48
6.20 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 48
6.21 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 49
6.22 Oct 27, 2016: Stryker reports third quarter 2016 results 50
6.23 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 51
6.24 Oct 25, 2016: RTI Surgical Announces 2016 Third Quarter Results 52
6.25 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 53
6.26 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 54
6.27 Aug 15, 2016: RTI Surgical Announces CEO Brian Hutchison to Retire 54
6.28 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 55
6.29 Jul 27, 2016: RTI Surgical Announces 2016 Second Quarter Results 55
6.30 Jul 25, 2016: CryoLife Reports Second Quarter 2016 Financial Results 57
6.31 Jul 21, 2016: Stryker reports second quarter 2016 results 58
7 Appendix 60
7.1 Methodology 60
7.2 About GlobalData 63
7.3 Contact Us 63
7.4 Disclaimer 63

1.1 List of Tables
Table 1: Nucleus Replacement - Pipeline Products by Stage of Development 7
Table 2: Nucleus Replacement - Pipeline Products by Territory 8
Table 3: Nucleus Replacement - Pipeline Products by Regulatory Path 9
Table 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date 10
Table 5: Nucleus Replacement - Ongoing Clinical Trials 11
Table 6: Nucleus Replacement Companies - Pipeline Products by Stage of Development 12
Table 7: Nucleus Replacement - Pipeline Products by Stage of Development 13
Table 8: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: NuReS - Product Status 14
Table 10: NuReS - Product Description 14
Table 11: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Chi2Disc - Product Status 15
Table 13: Chi2Disc - Product Description 15
Table 14: Clariance Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: NucleoFill - Product Status 16
Table 16: NucleoFill - Product Description 16
Table 17: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 18: Biodisc Nucleus Pulposus Replacement - Product Status 17
Table 19: Biodisc Nucleus Pulposus Replacement - Product Description 17
Table 20: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 21: Hydrafil - Product Status 18
Table 22: Hydrafil - Product Description 18
Table 23: Gentis Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 24: DiscCell - Product Status 19
Table 25: DiscCell - Product Description 19
Table 26: Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 27: Intervertebral Disc Repair System - Product Status 20
Table 28: Intervertebral Disc Repair System - Product Description 20
Table 29: Ortho Regenerative Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 30: Nucleus Pulposus Repair Device - Product Status 21
Table 31: Nucleus Pulposus Repair Device - Product Description 21
Table 32: Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 33: HydraFlex Nucleus Arthroplasty System - Product Status 22
Table 34: HydraFlex Nucleus Arthroplasty System - Product Description 22
Table 35: Replication Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 23
Table 36: NeuDisc - Product Status 23
Table 37: NeuDisc - Product Description 23
Table 38: Spine Wave Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 39: NuCore Injectable Nucleus - Product Status 24
Table 40: NuCore Injectable Nucleus - Product Description 24
Table 41: NuCore RPXL Injectable Nucleus - Product Status 25
Table 42: NuCore RPXL Injectable Nucleus - Product Description 25
Table 43: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 26
Table 44: Aquarelle - Product Status 26
Table 45: Aquarelle - Product Description 26
Table 46: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 47: Percutaneous Nucleus Replacement - Product Status 27
Table 48: Percutaneous Nucleus Replacement - Product Description 27
Table 49: Vertebral Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 50: InterCushion Disc Nucleus Replacement System - Product Status 28
Table 51: InterCushion Disc Nucleus Replacement System - Product Description 28
Table 52: Vertebral Technologies Inc - Ongoing Clinical Trials Overview 29
Table 53: InterCushion Disc Nucleus Replacement System - A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy 30
Table 54: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 55: Newcleus - Product Status 31
Table 56: Newcleus - Product Description 31
Table 57: Regain Lumbar Artificial Disc - Product Status 32
Table 58: Regain Lumbar Artificial Disc - Product Description 32
Table 59: Glossary 62

1.2 List of Figures
Figure 1: Nucleus Replacement - Pipeline Products by Stage of Development 7
Figure 2: Nucleus Replacement - Pipeline Products by Territory 8
Figure 3: Nucleus Replacement - Pipeline Products by Regulatory Path 9
Figure 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date 10
Figure 5: Nucleus Replacement - Ongoing Clinical Trials 11
Filed in: Medical Device, Orthopedic Devices
Publisher : GlobalData